Novavax and Serum Institute receive EUA for Covid-19 vaccine in Indonesia
The vaccine can be stored at 2 to 8 degrees celsius and traditional cold chain capabilities will suffice
The vaccine can be stored at 2 to 8 degrees celsius and traditional cold chain capabilities will suffice
Two leaders in science combine complementary best-in-class technologies for biologics manufacturing customers
Following the review of around 20 candidate vaccines by the external advisory group, MVC's vaccine was selected as one of two to be included in the global trial
Filing marks first protein-based vaccine submitted to MHRA for authorization
The quarter also saw continued investment in new technologies and the successful implementation of several digitization and automation projects across operations
The state-of-the-art facility provides a pathway from development to large-scale biologics production
Takeda to exclusively commercialize JR-141 outside the U.S. (except Japan and certain other Asia-Pacific countries) upon regulatory approval
The acquisition complements and strengthens Merck’s cardiovascular pipeline
It is a recombinant nanoparticle protein-based vaccine
The pivotal Phase 3 trial achieved all primary endpoints, demonstrating non-inferiority to a leading U.S.-licensed quadrivalent influenza vaccine
Subscribe To Our Newsletter & Stay Updated